Log In
BCIQ
Print this Print this
 

Liposome-Entrapped Paclitaxel (LEP)

Also known as: paclitaxel (LEP-ETU)

  Manage Alerts
Collapse Summary General Information
Company Insys Therapeutics Inc.
DescriptionLiposomal encapsulated paclitaxel (LEP) formulated using the NeoLipid technology
Molecular Target Tubulin
Mechanism of ActionMicrotubule stabilization
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$5.7M

$5.7M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/15/2010

$5.7M

$5.7M

0

Get a free BioCentury trial today